Clinical Trial

Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

Name: Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening — clinical trial record (NCT06879834)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ARTDR

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated March 17, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Summary

To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.

Trial Details

NCT Number	NCT06879834
Lead Sponsor	The Filatov Institute of Eye Diseases and Tissue Therapy Collaborators: CheckEye LLC, Oftacentro SA
Conditions	Diabetic Retinopathy
Enrollment	200 participants
Start Date	2024-11-02
Primary Completion	2025-08 (estimated)
Study Completion	2025-12 (estimated)
Updated on ClinicalTrials.gov	2025-03-17